Advanced search
Publication Cover
Emerging Microbes & Infections Volume 9, 2020 - Issue 1
Submit an article Journal homepage
6,559
Views
99
CrossRef citations to date
0
Altmetric
Articles

Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT)

Benjamin Meyera Centre for Vaccinology, Department of Pathology and Immunology, University of Geneva, Geneva, SwitzerlandORCID Iconhttps://orcid.org/0000-0003-0601-3550View further author information
ORCID Icon,
Johan Reimerinkb Centre for Infectious Disease Control, WHO COVID-19 reference laboratory, RIVM, Bilthoven, NetherlandsORCID Iconhttps://orcid.org/0000-0002-0785-8996View further author information
ORCID Icon,
Giulia Torrianic Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, SwitzerlandView further author information
,
Fion Brouwerb Centre for Infectious Disease Control, WHO COVID-19 reference laboratory, RIVM, Bilthoven, NetherlandsView further author information
,
Gert-Jan Godekeb Centre for Infectious Disease Control, WHO COVID-19 reference laboratory, RIVM, Bilthoven, NetherlandsView further author information
,
Sabine Yerlyd Laboratory of Virology, Geneva University Hospitals, Geneva, SwitzerlandView further author information
,
Marieke Hoogerwerfb Centre for Infectious Disease Control, WHO COVID-19 reference laboratory, RIVM, Bilthoven, NetherlandsView further author information
,
Nicolas Vuilleumiere Division of Laboratory Medicine, Department of Diagnostics, Geneva University Hospitals and Geneva University, Geneva, Switzerland;f Division of Laboratory Medicine, Department of Medicine, Faculty of Medicine, Geneva, SwitzerlandView further author information
,
Laurent Kaiserd Laboratory of Virology, Geneva University Hospitals, Geneva, Switzerland;g Division of Infectious Disease, Geneva University Hospitals, Geneva, Switzerland;h Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, SwitzerlandView further author information
,
Isabella Eckerlec Department of Microbiology and Molecular Medicine, University of Geneva, Geneva, Switzerland;g Division of Infectious Disease, Geneva University Hospitals, Geneva, Switzerland;h Geneva Centre for Emerging Viral Diseases, Geneva University Hospitals, Geneva, SwitzerlandCorrespondence[email protected] [email protected]
View further author information
&
Chantal Reuskenb Centre for Infectious Disease Control, WHO COVID-19 reference laboratory, RIVM, Bilthoven, NetherlandsORCID Iconhttps://orcid.org/0000-0003-4605-9174View further author information
ORCID Icon show all
Pages 2394-2403 | Received 03 Sep 2020, Accepted 07 Oct 2020, Published online: 01 Nov 2020

Citations (99)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Alexandra Rockstroh, Johannes Wolf, Jasmin Fertey, Sven Kalbitz, Stefanie Schroth, Christoph Lübbert, Sebastian Ulbert & Stephan Borte. (2021) Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort. Emerging Microbes & Infections 10:1, pages 774-781.
Read now

Articles from other publishers (98)

Norma A. Valdez‑Cruz, Diego Rosiles-Becerril, Constanza E. Martínez-Olivares, Enrique García‑Hernández, Laura Cobos-Marín, Daniel Garzón, Francisco E. López-Salas, Guadalupe Zavala, Axel Luviano, Alejandro Olvera, Alejandro Alagón, Octavio T. Ramírez & Mauricio A. Trujillo‑Roldán. (2024) Oral administration of a recombinant modified RBD antigen of SARS-CoV-2 as a possible immunostimulant for the care of COVID-19. Microbial Cell Factories 23:1.
Crossref
Ronald von Possel, Babett Menge, Christina Deschermeier, Carlos Fritzsche, Christoph Hemmer, Hilte Geerdes-Fenge, Micha Loebermann, Anette Schulz, Erik Lattwein, Katja Steinhagen, Ralf Tönnies, Reiner Ahrendt & Petra Emmerich. (2024) Performance Analysis of Serodiagnostic Tests to Characterize the Incline and Decline of the Individual Humoral Immune Response in COVID-19 Patients: Impact on Diagnostic Management. Viruses 16:1, pages 91.
Crossref
Asghar Abdoli, Hamidreza Jamshidi, Mohammad Taqavian, Mehdi Lari Baghal & Hasan Jalili. (2024) Omicron-specific and bivalent omicron-containing vaccine candidates elicit potent virus neutralisation in the animal model. Scientific Reports 14:1.
Crossref
Mohammad Suhail Khan, Virginie Jakob, Randhir Singh, Raju S. Rajmani, Sahil Kumar, Céline Lemoine, Harry Kleanthous, Rajesh P. Ringe, Patrice M. Dubois & Raghavan Varadarajan. (2023) Enhancing Immunogenicity of a Thermostable, Efficacious SARS-CoV-2 Vaccine Formulation through Oligomerization and Adjuvant Choice. Pharmaceutics 15:12, pages 2759.
Crossref
Michael Schoefbaenker, Rieke Neddermeyer, Theresa Guenther, Marlin M. Mueller, Marie-Luise Romberg, Nica Classen, Marc T. Hennies, Eike R. Hrincius, Stephan Ludwig, Joachim E. Kuehn & Eva U. Lorentzen. (2023) Surrogate Virus Neutralisation Test Based on Nanoluciferase-Tagged Antigens to Quantify Inhibitory Antibodies against SARS-CoV-2 and Characterise Omicron-Specific Reactivity in a Vaccination Cohort. Vaccines 11:12, pages 1832.
Crossref
Eveline Santos da Silva, Jean-Yves Servais, Michel Kohnen, Vic Arendt, Therese Staub, Rejko Krüger, Guy Fagherazzi, Paul Wilmes, Judith M. Hübschen, Markus Ollert, Danielle Perez-Bercoff & Carole Seguin-Devaux. (2023) Validation of a SARS-CoV-2 Surrogate Neutralization Test Detecting Neutralizing Antibodies against the Major Variants of Concern. International Journal of Molecular Sciences 24:19, pages 14965.
Crossref
Toshihiro Takahashi, Tomohiko Ai, Kaori Saito, Shuko Nojiri, Maika Takahashi, Gene Igawa, Takamasa Yamamoto, Abdullah Khasawneh, Faith Jessica Paran, Satomi Takei, Yuki Horiuchi, Takayuki Kanno, Minoru Tobiume, Makoto Hiki, Mitsuru Wakita, Takashi Miida, Atsushi Okuzawa, Tadaki Suzuki, Kazuhisa Takahashi, Toshio Naito & Yoko Tabe. (2023) Assessment of antibody dynamics and neutralizing activity using serological assay after SARS-CoV-2 infection and vaccination. PLOS ONE 18:9, pages e0291670.
Crossref
Diego Cantoni, Craig Wilkie, Emma M. Bentley, Martin Mayora-Neto, Edward Wright, Simon Scott, Surajit Ray, Javier Castillo-Olivares, Jonathan Luke Heeney, Giada Mattiuzzo & Nigel James Temperton. (2023) Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature. Frontiers in Immunology 14.
Crossref
Daisuke Ikeda, Ami Fukumoto, Yuka Uesugi, Rikako Tabata, Daisuke Miura, Kentaro Narita, Masami Takeuchi, Tomohisa Watari, Yoshihito Otsuka & Kosei Matsue. (2023) Clinical and immunological characteristics of prolonged SARS-CoV-2 Omicron infection in hematologic disease. Blood Cancer Journal 13:1.
Crossref
Bachirou Tinto, Justine Revel, Laurie Virolle, Baptiste Chenet, Florence Reboul Salze, Alix Ortega, Marielle Beltrame & Yannick Simonin. (2023) Monitoring SARS-CoV-2 Seroprevalence in Domestics and Exotic Animals in Southern France. Tropical Medicine and Infectious Disease 8:9, pages 426.
Crossref
Daniel Montes-Herrera, José Esteban Muñoz-Medina, Larissa Fernandes-Matano, Angel Gustavo Salas-Lais, Ma. De Los Ángeles Hernández-Cueto, Clara Esperanza Santacruz-Tinoco, Irma Eloisa Monroy-Muñoz & Javier Angeles-Martínez. (2023) Association of Obesity with SARS-CoV-2 and Its Relationship with the Humoral Response Prior to Vaccination in the State of Mexico: A Cross-Sectional Study. Diagnostics 13:16, pages 2630.
Crossref
Samar Samoud, Jihene Bettaieb, Mariem Gdoura, Ghassen Kharroubi, Feriel Ben Ghachem, Imen Zamali, Ahlem Ben Hmid, Sadok Salem, Ahmed Adel Gereisha, Mongi Dellagi, Nahed Hogga, Adel Gharbi, Amor Baccouche, Manel Gharbi, Chadha Khemissi, Ghada Akili, Wissem Slama, Nabila Chaieb, Yousr Galai, Hechmi Louzir, Henda Triki & Melika Ben Ahmed. (2023) Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial. Vaccines 11:8, pages 1329.
Crossref
Brittany Lavender, Caitlin Hooker, Chris Frampton, Michael Williams, Simon Carson, Aimee Paterson, Reuben McGregor, Nicole J. Moreland, Katie Gell, Frances H. Priddy, Kjesten Wiig, Graham Le Gros, James E. Ussher & Maia Brewerton. (2023) Robust immunogenicity of a third BNT162b2 vaccination against SARS-CoV-2 Omicron variant in a naïve New Zealand cohort. Vaccine 41:38, pages 5535-5544.
Crossref
Jadwiga Radziejewska, Jacek Arkowski, Robert Susło, Kamil Kędzierski & Magdalena Wawrzyńska. (2023) Analysis of COVID-19 Incidence and Protective Potential of Persisting IgG Class Antibodies against SARS-CoV-2 Infection in Hospital Staff in Poland. Vaccines 11:7, pages 1198.
Crossref
Laura Pezzati, Laura Milazzo, Giorgia Carrozzo, Cristina Kullmann, Letizia Oreni, Martina Beltrami, Stefania Caronni, Alessia Lai, Livio Caberlotto, Cosimo Ottomano, Spinello Antinori & Anna Lisa Ridolfo. (2023) Evaluation of residual humoral immune response against SARS-CoV-2 by a surrogate virus neutralization test (sVNT) 9 months after BNT162b2 primary vaccination. Journal of Infection and Chemotherapy 29:6, pages 624-627.
Crossref
Tatjana Vilibic-Cavlek, Maja Bogdanic, Ema Borko, Zeljka Hruskar, Denis Zilic, Thomas Ferenc, Irena Tabain, Ljubo Barbic, Mateja Vujica Ferenc, Ivana Ferencak & Vladimir Stevanovic. (2023) Detection of SARS-CoV-2 Antibodies: Comparison of Enzyme Immunoassay, Surrogate Neutralization and Virus Neutralization Test. Antibodies 12:2, pages 35.
Crossref
Gavriella Hecht, Nathan Sarbo, Wayne Svoboda, Heather L. Mead, Irene Ruberto, John A. Altin, David M. Engelthaler, Heather Venkat & Hayley D. Yaglom. (2023) “Sniffing” out SARS-CoV-2 in Arizona working dogs: an exploratory serosurvey. Frontiers in Veterinary Science 10.
Crossref
Fernando Alcorta-Nuñez, Diana Cristina Pérez-Ibave, Carlos Horacio Burciaga-Flores, Miguel Ángel Garza, Moisés González-Escamilla, Patricia Rodríguez-Niño, Juan Francisco González-Guerrero, Adelina Alcorta-Garza, Oscar Vidal-Gutiérrez, Genaro A. Ramírez-Correa & María Lourdes Garza-Rodríguez. (2023) SARS-CoV-2 Neutralizing Antibodies in Mexican Population: A Five Vaccine Comparison. Diagnostics 13:6, pages 1194.
Crossref
Miguel Hueda-Zavaleta, Juan C. Gómez de la Torre, José Alonso Cáceres-DelAguila, Cecilia Muro-Rojo, Nathalia De La Cruz-Escurra, Cesar Copaja-Corzo, Carlos J. Aragón-Ayala & Vicente A. Benítes-Zapata. (2023) Neutralizing Antibodies as Predictors of Vaccine Breakthrough Infection in Healthcare Workers Vaccinated with or without a Heterologous Booster Dose: A Cohort Study during the Third COVID-19 Wave in Peru. Vaccines 11:2, pages 447.
Crossref
Larissa Fernandes-Matano, Angel Gustavo Salas-Lais, Concepción Grajales-Muñiz, Mauricio Hernández-Ávila, Yonathan Omar Garfias-Becerra, Mario César Rodríguez-Sepúlveda, Carlos Segura-Sánchez, Daniel Montes-Herrera, Denisse Mendoza-Sánchez, Javier Angeles-Martínez, Andrea Santos Coy-Arechavaleta, Julio Elías Alvarado-Yaah, Clara Esperanza Santacruz-Tinoco, Eva Ramón-Gallegos & José Esteban Muñoz-Medina. (2023) Longevity and Neutralizing Capacity of IgG Antibodies against SARS-CoV-2 Generated by the Application of BNT162b2, AZD1222, Convidecia, Sputnik V, and CoronaVac Vaccines: a Cohort Study in the Mexican Population. Microbiology Spectrum 11:1.
Crossref
Takashi Higuchi, Shomi Oka, Hiroshi Furukawa & Shigeto Tohma. (2023) Associations of HLA Polymorphisms with Anti-SARS-CoV-2 Spike and Neutralizing Antibody Titers in Japanese Rheumatoid Arthritis Patients Vaccinated with BNT162b2. Vaccines 11:2, pages 404.
Crossref
Lina Mouna, Mehdi Razazian, Sandra Duquesne, Anne-Marie Roque-Afonso & Christelle Vauloup-Fellous. (2023) Validation of a SARS-CoV-2 Surrogate Virus Neutralization Test in Recovered and Vaccinated Healthcare Workers. Viruses 15:2, pages 426.
Crossref
Zonghong Luo, Ke Ni, Yuancheng Zhou, Guanhong Chang, Jiangtao Yu, Chunling Zhang, Wenqi Yin, Dishi Chen, Shuwei Li, Shengyao Kuang, Peng Zhang, Kui Li, Junqing Bai & Xin Wang. (2023) Inactivation of two SARS-CoV-2 virus surrogates by electron beam irradiation on large yellow croaker slices and their packaging surfaces. Food Control 144, pages 109340.
Crossref
Endeshaw Chekol Abebe & Tadesse Asmamaw Dejenie. (2023) Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications. Frontiers in Immunology 14.
Crossref
Marianne Graninger, Claudia Maria Jani, Elisabeth Reuberger, Katja Prüger, Philipp Gaspar, David Niklas Springer, Christian Borsodi, Lisa Weidner, Susanne Rabady, Elisabeth Puchhammer-Stöckl, Christof Jungbauer, Eva Höltl, Judith Helene Aberle, Karin Stiasny & Lukas Weseslindtner. (2023) Comprehensive Comparison of Seven SARS-CoV-2-Specific Surrogate Virus Neutralization and Anti-Spike IgG Antibody Assays Using a Live-Virus Neutralization Assay as a Reference. Microbiology Spectrum.
Crossref
John Merluza, Johnny Ung, Kai Makowski, Alyssia Robinson, Kathy Manguiat, Nicole Mueller, Jonathan Audet, Julie Chih-Yu Chen, James E. Strong, Heidi Wood & Alexander Bello. (2023) Validation and Establishment of the SARS-CoV-2 Lentivirus Surrogate Neutralization Assay as a Prescreening Tool for the Plaque Reduction Neutralization Test. Microbiology Spectrum.
Crossref
Xuesong Xu, Yi Hong, Erjing Chen, Yaping Wang, Biao Ma, Jiali Li, Wei Su, Yuxin Zhou & Mingzhou Zhang. (2022) Antibodies Induced by Homologous or Heterologous Inactivated (CoronaVac/BBIBP-CorV) and Recombinant Protein Subunit Vaccines (ZF2001) Dramatically Enhanced Inhibitory Abilities against B.1.351, B.1.617.2, and B.1.1.529 Variants. Vaccines 10:12, pages 2110.
Crossref
Elliot Poehler, Liam Gibson, Audrey Lustig, Nicole J Moreland, Reuben McGregor & Alex James. (2022) Estimating decay curves of neutralizing antibodies to SARS-CoV-2 infection. Mathematical Medicine and Biology: A Journal of the IMA 39:4, pages 368-381.
Crossref
Dewi Lokida, Muhammad Karyana, Herman Kosasih, Yan Mardian, Retna Indah Sugiyono, Dona Arlinda, Nurhayati Lukman, Gustiani Salim, Deni Pepy Butar butar, Adhella Menur Naysilla & Irmansyah. (2022) Performance and correlation of ten commercial immunoassays for the detection of SARS-CoV-2 antibodies. Heliyon 8:12, pages e12614.
Crossref
Xiangyu Yao, Zhichao Zhang, Qingmin Mei, Shenwei Li, Li Xing, Yali Long, Demei Zhang, Jing Wang, Xiedong Wang, Bin Xie, Bo Yang, Yong Gao, Changxin Wu & Qinglai Meng. (2022) A highly sensitive bead-based flow cytometric competitive binding assay to detect SARS-CoV-2 neutralizing antibody activity. Frontiers in Immunology 13.
Crossref
Hadeel T. Zedan, Hadi M. Yassine, Duaa W. Al-Sadeq, Na Liu, Hamda Qotba, Eleonora Nicolai, Massimo Pieri, Sergio Bernardini, Laith J. Abu-Raddad & Gheyath K. Nasrallah. (2022) Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies. Scientific Reports 12:1.
Crossref
Fabien Abdul, Pascale Ribaux, Aurélie Caillon, Astrid Malézieux-Picard, Virginie Prendki, Nathalie Vernaz, Nikolay Zhukovsky, Flavien Delhaes, Karl-Heinz Krause & Olivier Preynat-Seauve. (2022) A Cellular Assay for Spike/ACE2 Fusion: Quantification of Fusion-Inhibitory Antibodies after COVID-19 and Vaccination. Viruses 14:10, pages 2118.
Crossref
Waleemas Jairak, Kamonpan Charoenkul, Ekkapat Chamsai, Kitikhun Udom, Supassama Chaiyawong, Aphinya Hangsawek, Suchart Waenkaew, Anek Mungaomklang, Ratanaporn Tangwangvivat & Alongkorn Amonsin. (2022) Survey of SARS‐CoV‐2 in dogs and cats in high‐risk areas during the second wave of COVID‐19 outbreak, Thailand. Zoonoses and Public Health 69:6, pages 737-745.
Crossref
Ortwin Adams, Marcel Andrée, Derik Hermsen, Nadine Lübke, Jörg Timm, Heiner Schaal & Lisa Müller. (2022) Comparison of commercial SARS-CoV-2 surrogate neutralization assays with a full virus endpoint dilution neutralization test in two different cohorts. Journal of Virological Methods 307, pages 114569.
Crossref
Yi-Chou Hou, Chia-Lin Wu, Kuo-Cheng Lu & Ko-Lin Kuo. (2022) Indoxyl Sulfate Alters the Humoral Response of the ChAdOx1 COVID-19 Vaccine in Hemodialysis Patients. Vaccines 10:9, pages 1378.
Crossref
Hiroshi Furukawa, Shomi Oka, Takashi Higuchi, Moriyuki Nakama, Nobuhiro Nagai & Shigeto Tohma. (2022) Anti-SARS-CoV-2 Spike Antibody Titers and Neutralizing Antibodies in Vaccinated Rheumatoid Arthritis Patients. Vaccines 10:8, pages 1365.
Crossref
Sundararaj Stanleyraj Jeremiah, Kei Miyakawa & Akihide Ryo. (2022) Detecting SARS-CoV-2 neutralizing immunity: highlighting the potential of split nanoluciferase technology. Journal of Molecular Cell Biology 14:4.
Crossref
Victor H. Ferreira, Javier T. Solera, Queenie Hu, Victoria G. Hall, Berta G. Arbol, W. Rod Hardy, Reuben Samson, Tina Marinelli, Matthew Ierullo, Avneet Kaur Virk, Alexandra Kurtesi, Faranak Mavandadnejad, Beata Majchrzak-Kita, Vathany Kulasingam, Anne-Claude Gingras, Deepali Kumar & Atul Humar. (2022) Homotypic and heterotypic immune responses to Omicron variant in immunocompromised patients in diverse clinical settings. Nature Communications 13:1.
Crossref
Waleemas Jairak, Kamonpan Charoenkul, Ekkapat Chamsai, Kitikhun Udom, Supassama Chaiyawong, Napawan Bunpapong, Supanat Boonyapisitsopa, Rachod Tantilertcharoen, Navapon Techakriengkrai, Sirilak Surachetpong, Ratanaporn Tangwangvivat, Kamol Suwannakarn & Alongkorn Amonsin. (2021) First cases of SARS‐CoV‐2 infection in dogs and cats in Thailand. Transboundary and Emerging Diseases 69:4.
Crossref
Kitikhun Udom, Waleemas Jairak, Ekkapat Chamsai, Kamonpan Charoenkul, Supanat Boonyapisitsopa, Napawan Bunpapong, Navapon Techakriengkrai & Alongkorn Amonsin. (2021) Serological survey of antibodies against SARS‐CoV‐2 in dogs and cats, Thailand. Transboundary and Emerging Diseases 69:4, pages 2140-2147.
Crossref
Angelica Stranieri, Stefania Lauzi, Alessia Giordano, Luigi Galimberti, Gabriele Ratti, Nicola Decaro, Federica Brioschi, Davide Lelli, Silvia Gabba, Ndiana Linda Amarachi, Eleonora Lorusso, Ana Moreno, Tiziana Trogu & Saverio Paltrinieri. (2021) Absence of SARS‐CoV‐2 RNA and anti‐SARS‐CoV‐2 antibodies in stray cats. Transboundary and Emerging Diseases 69:4, pages 2089-2095.
Crossref
Qamar J. Khan, Cory R. Bivona, Ben Liu, Maggie Nelson, Grace A. Martin, Muhammad Umair Mushtaq, Priyanka Sharma, Natalie R. Streeter, Marc Hoffmann, Gary C. Doolittle, Cuncong Zhong, Laura Mitchell, Kevin H. Li, Ziyan Y. Pessetto, Arnab Ghosh, Harsh B. Pathak, Jun Zhang, Andrew K. Godwin & Joseph P. McGuirk. (2022) Prospective longitudinal study of kinetics of humoral response to one, two, or three doses of SARS-CoV-2 vaccine in hematopoietic cell transplant recipients. Bone Marrow Transplantation 57:6, pages 1013-1016.
Crossref
Yuchang Li, Mingyue Wang, Hongzhen Wu, Hui Zhao, Lei Dong, Yunfei Li, Xiaofeng Li, Ying Tang, Sen Zhang, Jing Li, Chengfeng Qin, Tao Jiang, Yongqiang Deng & Xiaoping Kang. (2022) Development of a rapid neutralizing antibody test for SARS-CoV-2 and its application for neutralizing antibody screening and vaccinated serum testing. Infectious Medicine 1:2, pages 95-102.
Crossref
Ngai Sze Wong, Shui Shan Lee, Denise P. C. Chan, Timothy C. M. Li, Tracy H. Y. Ho, Fion W. L. Luk, Kai Ming Chow, Eugene Y. K. Tso, Eng-Kiong Yeoh, Samuel Y. S. Wong, David S. C. Hui & Grace C. Y. Lui. (2022) Trajectory patterns of SARS-CoV-2 neutralising antibody response in convalescent COVID-19 patients. Communications Medicine 2:1.
Crossref
Waleemas Jairak, Ekkapat Chamsai, Kitikhun Udom, Kamonpan Charoenkul, Supassama Chaiyawong, Navapon Techakriengkrai, Ratanaporn Tangwangvivat, Kamol Suwannakarn & Alongkorn Amonsin. (2022) SARS-CoV-2 delta variant infection in domestic dogs and cats, Thailand. Scientific Reports 12:1.
Crossref
Kara L Lynch, Shuxia Zhou, Ravi Kaul, Roger Walker & Alan H Wu. (2022) Evaluation of Neutralizing Antibodies against SARS-CoV-2 Variants after Infection and Vaccination Using a Multiplexed Surrogate Virus Neutralization Test. Clinical Chemistry 68:5, pages 702-712.
Crossref
Rie Midorikawa, Moriyuki Nakama, Hiroshi Furukawa, Shomi Oka, Takashi Higuchi, Hideaki Nagai, Nobuhiro Nagai & Shigeto Tohma. (2022) Detection of SARS-CoV-2 Nucleocapsid, Spike, and Neutralizing Antibodies in Vaccinated Japanese. Viruses 14:5, pages 965.
Crossref
Tobias Niedrist, Camilla Drexler, Patrick Paul Torreiter, Julia Matejka, Manuela Strahlhofer-Augsten, Sabrina Kral, Skaiste Riegler, Christian Gülly, Christoph Zurl, Lisa Kriegl, Robert Krause, Andrea Berghold, Ivo Steinmetz, Peter Schlenke & Markus Herrmann. (2022) Longitudinal Comparison of Automated SARS-CoV-2 Serology Assays in Assessing Virus Neutralization Capacity in COVID-19 Convalescent Sera. Archives of Pathology & Laboratory Medicine 146:5, pages 538-546.
Crossref
Rapisa Nantanee, Puneyavee Aikphaibul, Peera Jaru-Ampornpan, Pimpayao Sodsai, Orawan Himananto, Tuangtip Theerawit, Jiratchaya Sophonphan, Punyot Tovichayathamrong, Kasama Manothummetha, Tysdi Laohasereekul, Narin Hiransuthikul, Nattiya Hirankarn & Thanyawee Puthanakit. (2022) Immunogenicity and reactogenicity after booster dose with AZD1222 via intradermal route among adult who had received CoronaVac. Vaccine 40:24, pages 3320-3329.
Crossref
Farah M. Shurrab, Nadin Younes, Duaa W. Al-Sadeq, Na Liu, Hamda Qotba, Laith J. Abu-Raddad & Gheyath K. Nasrallah. (2022) Performance evaluation of novel fluorescent-based lateral flow immunoassay (LFIA) for rapid detection and quantification of total anti-SARS-CoV-2 S-RBD binding antibodies in infected individuals. International Journal of Infectious Diseases 118, pages 132-137.
Crossref
Asghar Abdoli, Reza Aalizadeh, Hossein Aminianfar, Zahra Kianmehr, Ali Teimoori, Ebrahim Azimi, Nabbi Emamipour, Marzieh Eghtedardoost, Vahid Siavashi, Hamidreza Jamshidi, Mohammadreza Hosseinpour, Mohammad Taqavian & Hasan Jalili. (2021) Safety and potency of BIV1‐CovIran inactivated vaccine candidate for SARS‐CoV‐2: A preclinical study. Reviews in Medical Virology 32:3.
Crossref
Juan C. Gómez de la Torre, José Alonso Cáceres-DelAguila, Cecilia Muro-Rojo, Nathalia De La Cruz-Escurra, Cesar Copaja-Corzo, Miguel Hueda-Zavaleta, Daniella Arenas Siles & Vicente A Benites-Zapata. (2022) Humoral Immune Response Induced by the BBIBP-CorV Vaccine (Sinopharm) in Healthcare Workers: A Cohort Study. Tropical Medicine and Infectious Disease 7:5, pages 66.
Crossref
Minoo Mohraz, Mohammadreza Salehi, Payam Tabarsi, Mohsen Abbasi-Kangevari, Seyyed-Hadi Ghamari, Erfan Ghasemi, Maryam Amini Pouya, Negar Rezaei, Naser Ahmadi, Kazem Heidari, Mohammad-Reza Malekpour, Mojtaba Nasiri, Ali Akbar Amirzargar, Sahar Saeedi Moghaddam, Bagher Larijani & Hamed Hosseini. (2022) Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults. BMJ Open 12:4, pages e056872.
Crossref
Amanda Izeli Portilho, Gabrielle Gimenes Lima & Elizabeth De Gaspari. (2022) Enzyme-Linked Immunosorbent Assay: An Adaptable Methodology to Study SARS-CoV-2 Humoral and Cellular Immune Responses. Journal of Clinical Medicine 11:6, pages 1503.
Crossref
Lennart Münsterkötter, Moritz Maximilian Hollstein, Andreas Hahn, Andrea Kröger, Moritz Schnelle, Luise Erpenbeck, Uwe Groß, Hagen Frickmann & Andreas Erich Zautner. (2022) Comparison of the Anti-SARS-CoV-2 Surrogate Neutralization Assays by TECOmedical and DiaPROPH-Med with Samples from Vaccinated and Infected Individuals. Viruses 14:2, pages 315.
Crossref
Denis E. Kolesov, Maria V. Sinegubova, Lutsia K. Dayanova, Inna V. Dolzhikova, Ivan I. Vorobiev & Nadezhda A. Orlova. (2022) Fast and Accurate Surrogate Virus Neutralization Test Based on Antibody-Mediated Blocking of the Interaction of ACE2 and SARS-CoV-2 Spike Protein RBD. Diagnostics 12:2, pages 393.
Crossref
Mihaela Chivu‐Economescu, Coralia Bleotu, Camelia Grancea, Daniela Chiriac, Anca Botezatu, Iulia V. Iancu, Ioana Pitica, Laura G. Necula, Ana Neagu, Lilia Matei, Denisa Dragu, Camelia Sultana, Elena L. Radu, Alina Nastasie, Oana Voicu, Marius Ataman, Saviana Nedeianu, Cristina Mambet, Carmen C. Diaconu & Simona Maria Ruta. (2022) Kinetics and persistence of cellular and humoral immune responses to SARS‐CoV‐2 vaccine in healthcare workers with or without prior COVID‐19. Journal of Cellular and Molecular Medicine 26:4, pages 1293-1305.
Crossref
Hannah E Clapham, Wan Ni Chia, Linda Wei Lin Tan, Vishakha Kumar, Jane M Lim, Nivedita Shankar, Zaw Myo Tun, Marina Zahari, Li Yang Hsu, Louisa Jin Sun, Lin Fa Wang & Clarence C Tam. (2022) Contrasting SARS-CoV-2 epidemics in Singapore: cohort studies in migrant workers and the general population. International Journal of Infectious Diseases 115, pages 72-78.
Crossref
Giacomo Malipiero & Danilo Villalta. (2022) Answer to the letter of Lippi & Plebani entitled “Not all SARS-CoV-2 IgG and neutralizing antibody assays are created equal”. Clinica Chimica Acta 526, pages 21-22.
Crossref
Giuseppe Lippi & Mario Plebani. (2022) Not all SARS-CoV-2 IgG and neutralizing antibody assays are created equal. Clinica Chimica Acta 526, pages 81-82.
Crossref
Raquel Guiomar, Ana João Santos, Aryse Martins Melo, Inês Costa, Rita Matos, Ana Paula Rodrigues, Irina Kislaya, Anabela Santos Silva, Carla Roque, Carla Nunes, Joaquim Aguiar, Fátima Graça, Antônio Silva Graça & Ausenda Machado. (2022) Monitoring of SARS-CoV-2 Specific Antibodies after Vaccination. Vaccines 10:2, pages 154.
Crossref
Alexander Krüttgen, Gerhard Haase, Helga Haefner, Matthias Imöhl & Michael Kleines. (2022) Large inter-individual variability of cellular and humoral immunological responses to mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in health care workers. Clinical and Experimental Vaccine Research 11:1, pages 96.
Crossref
Hanna KlingelMaike LauenAlexander Krüttgen, Matthias Imöhl & Michael Kleines. (2022) Severity of adverse reactions is associated with T-cell response in mRNA-1273 vaccinated health care workers. Clinical and Experimental Vaccine Research 11:1, pages 121.
Crossref
Sera Lim, Yuil Lee, Dong Wan Kim, Won Sang Park, Jung Hwan Yoon & Jung Young Lee. (2022) Anti-SARS-CoV-2 Neutralizing Antibody Responses after Two Doses of ChAdOx1 nCoV-19 vaccine (AZD1222) in Healthcare Workers. Infection & Chemotherapy 54:1, pages 140.
Crossref
Alexander Krüttgen, Maike Lauen, Hanna Klingel, Matthias Imöhl & Michael Kleines. (2022) Two novel SARS-CoV-2 surrogate virus neutralization assays are suitable for assessing successful immunization with mRNA-1273. Journal of Virological Methods 299, pages 114297.
Crossref
Giacomo Malipiero, Pierlanfranco D'Agaro, Ludovica Segat, Anna Moratto & Danilo Villalta. (2022) Long-term decay of anti-RBD IgG titers after BNT162b2 vaccination is not mirrored by loss of neutralizing bioactivity against SARS-CoV-2. Clinica Chimica Acta 524, pages 11-17.
Crossref
Silvano Wendel, Roberta Fachini, Rita C. L. Fontão‐Wendel, Ralyria Mello, Carlos Vinícius Velasquez, Rafael Rahal Guaragna Machado, Mayra Altobelli Brito, Marcelo Amaral, Camila Pereira Soares, Ruth Achkar, Patrícia Scuracchio, Sandra Cristina Miyaji, Melina Santos Erdens & Edison Luiz Durigon. (2021) Surrogate test performance for SARS‐CoV ‐2 neutralizing antibodies ( nAbs ) for convalescent plasma ( CCP ): How useful could they be? . Transfusion 61:12, pages 3455-3467.
Crossref
Hayley D. Yaglom, Gavriella Hecht, Andrew Goedderz, Daniel Jasso-Selles, Jennifer L. Ely, Irene Ruberto, Jolene R. Bowers, David M. Engelthaler & Heather Venkat. (2021) Genomic investigation of a household SARS-CoV-2 disease cluster in Arizona involving a cat, dog, and pet owner. One Health 13, pages 100333.
Crossref
Carmen W.E. Embregts, Babs Verstrepen, Jan A.M. Langermans, Kinga P. Böszörményi, Reina S. Sikkema, Rory D. de Vries, Donata Hoffmann, Kerstin Wernike, Lidwien A.M. Smit, Shan Zhao, Barry Rockx, Marion P.G. Koopmans, Bart L. Haagmans, Thijs Kuiken & Corine H. GeurtsvanKessel. (2021) Evaluation of a multi-species SARS-CoV-2 surrogate virus neutralization test. One Health 13, pages 100313.
Crossref
Joanna Jung, Deepthi Rajapakshe, Christopher Julien & Sridevi Devaraj. (2021) Analytical and clinical performance of cPass neutralizing antibodies assay. Clinical Biochemistry 98, pages 70-73.
Crossref
Joachim Mariën, Johan Michiels, Leo Heyndrickx, Antoine Nkuba-Ndaye, Ann Ceulemans, Koen Bartholomeeusen, Joule Madinga, Placide Mbala-Kingebeni, Veerle Vanlerberghe, Steve Ahuka-Mundeke, Lin-Fa Wang & Kevin K. Ariën. (2021) Evaluation of a surrogate virus neutralization test for high-throughput serosurveillance of SARS-CoV-2. Journal of Virological Methods 297, pages 114228.
Crossref
Bastian Fischer, Christoph Lichtenberg, Lisa Müller, Jörg Timm, Johannes Fischer & Cornelius Knabbe. (2021) A combined strategy to detect plasma samples reliably with high anti-SARS-CoV-2 neutralizing antibody titers in routine laboratories. Journal of Clinical Virology 144, pages 104984.
Crossref
Cong Wang, Ze Wu, Bochao Liu, Panli Zhang, Jinhui Lu, Jinfeng Li, Peng Zou, Tingting Li, Yongshui Fu, Ruiai Chen, Ling Zhang, Qiangqiang Fu & Chengyao Li. (2021) Track-etched membrane microplate and smartphone immunosensing for SARS-CoV-2 neutralizing antibody. Biosensors and Bioelectronics 192, pages 113550.
Crossref
Xiaoguang Li, Chao Liang & Xiumei Xiao. (2021) SARS-CoV-2 Neutralizing Antibody Levels Post COVID-19 Vaccination Based on ELISA Method—A Small Real-World Sample Exploration. Vaccines 9:10, pages 1139.
Crossref
Vijayalakshmi NandakumarTracie ProfaizerBucky K. LozierMarc G. ElgortErin T. LarragoiteElizabeth S. C. P. WilliamsAntonio Solis-LealJ. Brandon LopezBradford K. BergesVicente PlanellesJenna RychertPatricia R. SlevJulio C. Delgado. (2021) Evaluation of a Surrogate Enzyme-Linked Immunosorbent Assay–Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation With Immunoglobulin G Commercial Serology Assays. Archives of Pathology & Laboratory Medicine 145:10, pages 1212-1220.
Crossref
Maria Vono, Angela Huttner, Sylvain Lemeille, Paola Martinez-Murillo, Benjamin Meyer, Stephanie Baggio, Shilpee Sharma, Anais Thiriard, Arnaud Marchant, Gert-Jan Godeke, Chantal Reusken, Catia Alvarez, Francisco Perez-Rodriguez, Isabella Eckerle, Laurent Kaiser, Natasha Loevy, Christiane S. Eberhardt, Geraldine Blanchard-Rohner, Claire-Anne Siegrist & Arnaud M. Didierlaurent. (2021) Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity. Cell Reports 37:1, pages 109773.
Crossref
Carlos Sariol, Petraleigh Pantoja, Crisanta Serrano-Collazo, Tiffany Rosa-Arocho, Albersy Armina-Rodríguez, Lorna Cruz, E. Stone, Teresa Arana, Consuelo Climent, Gerardo Latoni, Dianne Atehortua, Christina Pabon-Carrero, Amelia Pinto, James Brien & Ana Espino. (2021) Function Is More Reliable than Quantity to Follow Up the Humoral Response to the Receptor-Binding Domain of SARS-CoV-2-Spike Protein after Natural Infection or COVID-19 Vaccination. Viruses 13:10, pages 1972.
Crossref
Jorge Hernández-Bello, José Javier Morales-Núñez, Andrea Carolina Machado-Sulbarán, Saúl Alberto Díaz-Pérez, Paola Carolina Torres-Hernández, Paulina Balcázar-Félix, Jesús Alberto Gutiérrez-Brito, José Alvaro Lomelí-Nieto & José Francisco Muñoz-Valle. (2021) Neutralizing Antibodies against SARS-CoV-2, Anti-Ad5 Antibodies, and Reactogenicity in Response to Ad5-nCoV (CanSino Biologics) Vaccine in Individuals with and without Prior SARS-CoV-2. Vaccines 9:9, pages 1047.
Crossref
Emily N. Gallichotte, Mary Nehring, Michael C. Young, Sierra Pugh, Nicole R. Sexton, Emily Fitzmeyer, Kendra M. Quicke, Megan Richardson, Kristy L. Pabilonia, Nicole Ehrhart, Bailey K. Fosdick, Sue VandeWoude & Gregory D. Ebel. (2021) Durable Antibody Responses in Staff at Two Long-Term Care Facilities, during and Post SARS-CoV-2 Outbreaks. Microbiology Spectrum 9:1.
Crossref
Tom G. Caniels, Ilja Bontjer, Karlijn van der Straten, Meliawati Poniman, Judith A. BurgerBrent Appelman, A. H. Ayesha Lavell, Melissa OomenGert-Jan GodekeCoralie Valle, Ramona MöglingHugo D. G. van WilligenElke WynbergMichiel Schinkel, Lonneke A. van VughtDenise Guerra, Jonne L. SnitselaarDevidas N. Chaturbhuj, Isabel Cuella Martin, John P. Moore, Menno D. de Jong, Chantal Reusken, Jonne J. Sikkens, Marije K. Bomers, Godelieve J. de Bree, Marit J. van Gils, Dirk Eggink & Rogier W. Sanders. (2021) Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccination. Science Advances 7:36.
Crossref
Yuying Lu, Jin Wang, Qianlin Li, Huan Hu, Jiahai Lu & Zeliang Chen. (2021) Advances in Neutralization Assays for SARS‐CoV‐2. Scandinavian Journal of Immunology 94:3.
Crossref
Anuradha Rajamanickam, Nathella Pavan Kumar, Chandrasekaran Padmapriyadarsini, Arul Nancy, Nandhini Selvaraj, Kushiyasri Karunanithi, Saravanan Munisankar, Shrinivasa BM, Rachel Mariam Renji, T.C. Ambu, Vijayalakshmi Venkataramani & Subash Babu. (2021) Latent tuberculosis co-infection is associated with heightened levels of humoral, cytokine and acute phase responses in seropositive SARS-CoV-2 infection. Journal of Infection 83:3, pages 339-346.
Crossref
Kiwook Jung, Sue Shin, Minjeong Nam, Yun Ji Hong, Eun Youn Roh, Kyoung Un Park & Eun Young Song. (2021) Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre‐pandemic controls. Journal of Clinical Laboratory Analysis 35:9.
Crossref
Inna Sekirov, Martin Petric, Erin Carruthers, David Lawrence, Tamara Pidduck, Jesse Kustra, Jonathan Laley, Min-Kuang Lee, Navdeep Chahil, Annie Mak, Paul N. Levett, Emelissa Mendoza, Heidi Wood, Mike Drebot, Mel Krajden & Muhammad Morshed. (2021) Performance comparison of micro-neutralization assays based on surrogate SARS-CoV-2 and WT SARS-CoV-2 in assessing virus-neutralizing capacity of anti-SARS-CoV-2 antibodies. Access Microbiology 3:8.
Crossref
Seri Jeong, Nuri Lee, Su Kyung Lee, Eun-Jung Cho, Jungwon Hyun, Min-Jeong Park, Wonkeun Song, Eun Ju Jung, Heungjeong Woo, Yu Bin Seo, Jin Ju Park & Hyun Soo Kim. (2021) Comparing Results of Five SARS-CoV-2 Antibody Assays Before and After the First Dose of ChAdOx1 nCoV-19 Vaccine among Health Care Workers. Journal of Clinical Microbiology 59:9.
Crossref
José Javier Morales-Núñez, José Francisco Muñoz-Valle, Carlos Meza-López, Lin-Fa Wang, Andrea Carolina Machado Sulbarán, Paola Carolina Torres-Hernández, Martín Bedolla-Barajas, Brenda De la O-Gómez, Paulina Balcázar-Félix & Jorge Hernández-Bello. (2021) Neutralizing Antibodies Titers and Side Effects in Response to BNT162b2 Vaccine in Healthcare Workers with and without Prior SARS-CoV-2 Infection. Vaccines 9:7, pages 742.
Crossref
Deli Huang, Jenny Tuyet Tran, Linghang Peng, Linlin Yang, Raymond T. Suhandynata, Melissa A. Hoffman, Fangzhu Zhao, Ge Song, Wan-ting He, Oliver Limbo, Sean Callaghan, Elise Landais, Raiees Andrabi, Devin Sok, Joseph G. Jardine, Dennis R. Burton, James E. Voss, Robert L. Fitzgerald & David Nemazee. (2021) A Rapid Assay for SARS-CoV-2 Neutralizing Antibodies That Is Insensitive to Antiretroviral Drugs. The Journal of Immunology 207:1, pages 344-351.
Crossref
Franziska Neumann, Ruben Rose, Janine Römpke, Olaf Grobe, Thomas Lorentz, Helmut Fickenscher & Andi Krumbholz. (2021) Development of SARS-CoV-2 Specific IgG and Virus-Neutralizing Antibodies after Infection with Variants of Concern or Vaccination. Vaccines 9:7, pages 700.
Crossref
Yiqi Ruben Luo, Cassandra Yun, Indrani Chakraborty, Alan H. B. Wu & Kara L. Lynch. (2021) A SARS-CoV-2 Label-Free Surrogate Virus Neutralization Test and a Longitudinal Study of Antibody Characteristics in COVID-19 Patients. Journal of Clinical Microbiology 59:7.
Crossref
A. V. Gracheva, E. R. Korchevaya, A. M. Kudryashova, O. V. Borisova, O. A. Petrusha, D. I. Smirnova, I. N. Chernyshova, O. A. Svitich, V. V. Zverev & E. B. Faizuloev. (2021) Adaptation of the MTT assay for detection of neutralizing antibodies against the SARS-CoV-2 virus. Journal of microbiology, epidemiology and immunobiology 98:3, pages 253-265.
Crossref
Matthew J. Murray, Megan McIntosh, Claire Atkinson, Tabitha Mahungu, Edward Wright, Wendy Chatterton, Michael Gandy & Matthew B. Reeves. (2021) Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay. Journal of Infection 82:5, pages 170-177.
Crossref
Joe James, Shelley Rhodes, Craig S. Ross, Paul Skinner, Samuel P. Smith, Rebecca Shipley, Caroline J. Warren, Hooman Goharriz, Lorraine M. McElhinney, Nigel Temperton, Edward Wright, Anthony R. Fooks, Tristan W. Clark, Sharon M. Brookes, Ian H. Brown & Ashley C. Banyard. (2021) Comparison of Serological Assays for the Detection of SARS-CoV-2 Antibodies. Viruses 13:4, pages 713.
Crossref
Yuan Liang Woon, Yee Leng Lee, Yoong Min Chong, Nor Aliya Ayub, Swarna Lata Krishnabahawan, June Fei Wen Lau, Ramani Subramaniam-Kalianan, I-Ching Sam, Yoke Fun Chan, Raj Kumar Sevalingam, Azura Ramli, Chuan Huan Chuah, Hani Mat-Hussin, Chee Loon Leong, Suresh Kumar Chidambaram, Kalaiarasu M. Peariasamy & Pik Pin Goh. (2021) Serology surveillance of SARS-CoV-2 antibodies among healthcare workers in COVID-19 designated facilities in Malaysia. The Lancet Regional Health - Western Pacific 9, pages 100123.
Crossref
Da Luo, Yi Zhang, Minyu Wang, Chen Zhu, Yue Yao, Weifeng Yao, Li Zhang & Fang-Fang Cheng. (2021) Multifunctional titanium phosphate carriers for enhancing drug delivery and evaluating real-time therapeutic efficacy of a hydrophobic drug component in Euphorbia kansui . The Analyst 146:5, pages 1620-1625.
Crossref
Federico Gobbi, Dora Buonfrate, Lucia Moro, Paola Rodari, Chiara Piubelli, Sara Caldrer, Silvia Riccetti, Alessandro Sinigaglia & Luisa Barzon. (2021) Antibody Response to the BNT162b2 mRNA COVID-19 Vaccine in Subjects with Prior SARS-CoV-2 Infection. Viruses 13:3, pages 422.
Crossref
Christine von Rhein, Tatjana Scholz, Lisa Henss, Romy Kronstein-Wiedemann, Tatjana Schwarz, Roman N. Rodionov, Victor M. Corman, Torsten Tonn & Barbara S. Schnierle. (2021) Comparison of potency assays to assess SARS-CoV-2 neutralizing antibody capacity in COVID-19 convalescent plasma. Journal of Virological Methods 288, pages 114031.
Crossref
Stephan Schlickeiser, Tatjana Schwarz, Sophie Steiner, Kirsten Wittke, Nabeel Al Besher, Oliver Meyer, Ulrich Kalus, Axel Pruß, Florian Kurth, Thomas Zoller, Martin Witzenrath, Leif Erik Sander, Marcel A. Müller, Carmen Scheibenbogen, Hans-Dieter Volk, Christian Drosten, Victor M. Corman & Leif G. Hanitsch. (2021) Disease Severity, Fever, Age, and Sex Correlate With SARS-CoV-2 Neutralizing Antibody Responses. Frontiers in Immunology 11.
Crossref
Marijn Thijssen, Timothy Devos, Hanieh-Sadat Ejtahed, Samad Amini-Bavil-Olyaee, Ali Akbar Pourfathollah & Mahmoud Reza Pourkarim. (2020) Convalescent Plasma against COVID-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases. Microorganisms 8:11, pages 1733.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.